Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data.
Jennifer S GewandterAmber S KlecknerJames H MarshallJeffrey S BrownLesley H CurtisJavier BautistaRobert H DworkinIan R KlecknerNoah KolbSupriya G MohileKaren M MustianPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2019)
These data suggest that as used currently by clinicians, administrative codes likely underestimate CIPN incidence. Thus, studies using administrative data to estimate CIPN incidence are not currently feasible. However, the drug-induced polyneuropathy code is a specific indicator of CIPN in administrative data and may be useful for investigating predictors or potentially preventive therapies of CIPN.